Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.685
0.00 (0.00%)
Aug 12, 2025, 8:00 PM EDT
Silence Therapeutics Employees
Silence Therapeutics had 116 employees as of December 31, 2024. The number of employees increased by 7 or 6.42% compared to the previous year.
Employees
116
Change (1Y)
7
Growth (1Y)
6.42%
Revenue / Employee
$234,216
Profits / Employee
-$682,121
Market Cap
276.32M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
Longduoduo Company | 49 |
Silence Therapeutics News
- 7 days ago - Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 2 months ago - Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera - Business Wire
- 3 months ago - Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 3 months ago - Silence Therapeutics Welcomes Tim McInerney to Board of Directors - Business Wire
- 5 months ago - Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference - Business Wire
- 5 months ago - Silence Therapeutics plc (SLN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Silence Therapeutics plc 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 5 months ago - Silence Therapeutics PLC (SLNCF) Reports Full Year 2024 Financial Results with Strong Cash ... - GuruFocus